Citations for
1TAC1, TACR1
Neurotransmitter substance P mediates pancreatic cancer perineural invasion via NK-1R in cancer cells.
Li X, Ma G, Ma Q, Li W, Liu J, Han L, Duan W, Xu Q, Liu H, Wang Z, Sun Q, Wang F, Wu E.
Mol Cancer Res 11(3):294-302. doi: 10.1158/1541-7786.MCR-12-0609. Epub 2013 Jan 23. 2013
2TAC1
Substance P decreases fat storage and increases adipocytokine production in 3T3-L1 adipocytes.
Miegueu P, St-Pierre DH, Lapointe M, Poursharifi P, Lu H, Gupta A, Cianflone K.
Am J Physiol Gastrointest Liver Physiol 304(4):G420-7. doi: 10.1152/ajpgi.00162.2012. Epub 2012 Dec 20. 2013
3TAC1, TACR1
Substance P-neurokinin-1 receptor interaction upregulates monocyte tissue factor.
Khan MM, Douglas SD, Benton TD.
J Neuroimmunol 242(1-2):1-8. doi: 10.1016/j.jneuroim.2011.10.012. Epub 2011 Nov 23. 2012
4TAC1, TACR1
Substance P (SP)-neurokinin-1 receptor (NK-1R) alters adipose tissue responses to high-fat diet and insulin action.
Karagiannides I, Stavrakis D, Bakirtzi K, Kokkotou E, Pirtskhalava T, Nayeb-Hashemi H, Bowe C, Bugni JM, Nuņo M, Lu B, Gerard NP, Leeman SE, Kirkland JL, Pothoulakis C.
Endocrinology 152(6):2197-205. doi: 10.1210/en.2010-1345. Epub 2011 Apr 5. 2011
5TAC1, TACR1
Neurokinin-1 receptor: functional significance in the immune system in reference to selected infections and inflammation.
Douglas SD, Leeman SE.
Ann N Y Acad Sci 1217:83-95. doi: 10.1111/j.1749-6632.2010.05826.x. Epub 2010 Nov 22. Review. 2011
6TAC1, TACR1
Substance P inhibits natural killer cell cytotoxicity through the neurokinin-1 receptor.
Monaco-Shawver L, Schwartz L, Tuluc F, Guo CJ, Lai JP, Gunnam SM, Kilpatrick LE, Banerjee PP, Douglas SD, Orange JS.
J Leukoc Biol 89(1):113-25. doi: 10.1189/jlb.0410200. Epub 2010 Oct 12. 2011
7MME, TAC1
CD10-bearing fibroblasts may inhibit skin inflammation by down-modulating substance P.
Xie L, Takahara M, Nakahara T, Oba J, Uchi H, Takeuchi S, Moroi Y, Furue M.
Arch Dermatol Res 303(1):49-55. doi: 10.1007/s00403-010-1093-9. Epub 2010 Nov 13. 2011
8TAC1
Aberrant silencing of the endocrine peptide gene tachykinin-1 in gastric cancer.
David S, Kan T, Cheng Y, Agarwal R, Jin Z, Mori Y.
Biochem Biophys Res Commun 378(3):605-9. Epub 2008 Nov 29. 2009
9TAC1, TACR1
Substance P and NK-1R expression in oral precancerous epithelium.
Gonzalez-Moles MA, Brener S, Ruiz-Avila I, Gil-Montoya JA, Tostes D, Bravo M, Esteban F.
Oncol Rep 22(6):1325-31. 2009
10TAC1
Substance P mediates antiapoptotic responses in human colonocytes by Akt activation.
Koon HW, Zhao D, Zhan Y, Moyer MP, Pothoulakis C.
Proc Natl Acad Sci U S A 104(6):2013-8. Epub 2007 Jan 30. 2007
11TAC1
Tachykinin 1 (TAC1) gene SNPs and haplotypes with autism: a case-control study.
Marui T, Funatogawa I, Koishi S, Yamamoto K, Matsumoto H, Hashimoto O, Nanba E, Nishida H, Sugiyama T, Kasai K, Watanabe K, Kano Y, Kato N, Sasaki T.
Brain Dev 29(8):510-3. Epub 2007 Mar 21. 2007
12TAC1
Transport of somatostatin and substance P by human P-glycoprotein.
Uchiyama-Kokubu N, Naito M, Nakajima M, Tsuruo T.
FEBS Lett 574(1-3):55-61. 2004
13TAC1
Tachykinins regulate the function of platelets.
Graham GJ, Stevens JM, Page NM, Grant AD, Brain SD, Lowry PJ, Gibbins JM.
Blood 104(4):1058-65. Epub 2004 May 6. 2004
14TAC1
Substance P in human tears.
Yamada M, Ogata M, Kawai M, Mashima Y, Nishida T.
Cornea 22(7 Suppl):S48-54. 2003
15TAC1
Tachykinin (substance-P) gene expression in Leydig cells of the human and mouse testis.
Chiwakata C, et al.
Endocrinology 128(5):2441-8. 1991
16TAC1
RFLPs associated with the substance P-neurokinin A gene (NKNA).
Miguel C de, et al.
Nucleic Acids Res 16 : 1644. 1988
17TAC1, TAC3
The chromosomal location of the two human tackykinin genes : human substance P and neurokinin K.
Bonner TI, et al.
(HGM9) Cytogenet Cell Genet 46 : 584. 1987